cancer screening

News

Magnifying glass held by a human hand over a group of paper people cutouts in different colours

Denying prostate cancer screening 'no longer rational'

A German study has stoked debate about the merits of screening for prostate cancer, which is lagging behind breast cancer screening in Europe.

News

Elderly man talks to younger female nurse beside a Grail screening vehicle

Grail's multi-cancer test fluffs its lines in UK trial

Grail's Galleri blood test for cancer screening missed the mark in the much-anticipated NHS-Galleri trial, wreaking havoc with the firm's share price.

News

Grail multi-cancer test taps into Hims & Hers network

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test for cancer screening.

Oncology

pharmaphorum podcast Episode 229, Craig Eagle, Guardant Health

How blood tests can inform cancer treatment decisions, with ...

Craig Eagle, chief medical officer of Guardant Health, discusses blood as a rich source of biomarker development in cancer prognosis.

News

Doctor speaks with patient in his consultation room

Limited prostate cancer screening backed in UK

A recommendation on prostate cancer screening has been delivered in the UK, upsetting patient groups whilst being endorsed by medical organisations.

News

ESMO: Grail's data on cancer blood test firms up

Data from a new phase 3 trial of Grail's blood test for multiple cancers show improved efficacy and a lower rate of false alarms than a prior study.

Denying prostate cancer screening 'no longer rational'

Grail's multi-cancer test fluffs its lines in UK trial

Grail multi-cancer test taps into Hims & Hers network

How blood tests can inform cancer treatment decisions, with ...

Limited prostate cancer screening backed in UK

ESMO: Grail's data on cancer blood test firms up

Novartis snaps up PI3Kα breast cancer drug in $3bn deal

Using AI-driven synthetic personas to take your insights fur...

cancer screening

Editor's Picks